Neurolymphomatosis (NL) is an uncommon clinical condition, characterised by lymphomatous infiltration of the central and/or peripheral nervous system. Most often it is caused by B-cell non-Hodgkin's lymphoma (NHL). Clinically, patients usually present with neuropathy involving the nerve roots, plexuses, peripheral or cranial nerves. NL usually occurs as a complication of prior lymphoma, but it can also present in the form of relapsed lymphoma. It is important to diagnose and start early treatment in all cases of nodal or visceral (including neural) lymphoma with chemo and/or radiation therapy. The PET-CT and MRI can help in making diagnosis. We are presenting a case of 28-year male patient, diagnosed as diffuse large B-cell lymphoma on the background of follicular lymphoma, which initially responded to treatment but then presented with NL, based on clinical history and radiological findings which were confirmed by histopathology.
INTRODUCTION
Neurolymphomatosis (NL) is a rare clinical complication, which is characterised by nerve infiltration by neurotropic malignant cells in acute leukemia or non-Hodgkin's lymphoma (NHL) 1 with an estimated incidence of 0.2%. 2 Magnetic resonance imaging (MRI) and positron emission tomography-computed tomography (PET-CT) are the key imaging tools in making diagnosis. 3, 4 Its early diagnosis and treatment are imperative for better outcome. Herein, we present a case of a 28-year male with diffuse large B-cell lymphoma, who presented with this complication. He responded well to repeat therapy of lymphoma and is doing well till last follow-up.
CASE REPORT
A 28-year male patient presented to the walk-in clinic in April 2018 with left sided abdominal pain. CT scan was performed which showed large confluent nodal mass in mesentery with diffuse small bowel wall thickening. Patient underwent excisional biopsy of the mesenteric node in the peripheral hospital, which revealed large B-cell lymphoma in the background of follicular lymphoma. Subsequently, patient underwent chemotherapy, to which he responded well. On the follow-up sequential CT scans, there was good partial treatment response (according to Recist criteria); but unfortunately, after few months in February 2019, he presented to ER for right calf pain, swelling and numbness. Subsequently, ultrasound was requested by ER physician to rule out deep venous thrombosis (DVT). On ultrasound, there was no evidence of DVT. However, diffuse abnormal thickening of the right sciatic nerve was found from midposterior thigh extending down to the popliteal fossa with further thickening of the right tibial and common peroneal nerves (Figure 1 A,B ). For further assessment of ultrasound findings, MRI was requested, which revealed diffuse thickening of the sciatic nerve extending from mid-thigh down to the popliteal region, showing diffuse post-contrast enhancement and diffusion restriction. Similar signal abnormality was also seen involving the tibial nerve in the popliteal fossa with significant signal changes in the associated posterior compartment muscles (Figure 2 A-E). On the basis of these findings, diagnosis of NL, involving the sciatic and tibial nerves, was made. The case was then discussed in lymphoma conference; which further advised PET-CT scan for restaging of lymphoma and assessment of sciatic and tibial nerves and biopsy for confirmatory tissue diagnosis. 18F FDG PET-CT was performed which also showed diffuse hypermetabolic thickening of sciatic and tibial nerves with activity of 21.5 standard uptake value (SUV) and hypodense hypermetabolic posterior compartment muscles ( Figure 3A ). This further supported the radiological findings of NL. Patient later underwent biopsy of the enlarged hypermetabolic popliteal node, which showed large B-cell lymphoma as direct biopsy from the nerve was refused by the patient. Currently, patient is under chemotherapy and interim scan showed excellent treatment response with significant interval reduction in sciatic and tibial nerves involvement and perineural fat and muscular involvement. However, residual disease still showed mild hypermetabolic activity that is above background liver activity ( Figure 3B ).
DISCUSSION
Neurolymphomatosis (NL) is a rare entity; characterised by lymphocytic infiltration of the cranial and peripheral nerves. Literature review shows that NL is usually seen in relation with NHL 4,5 which is in line with our case, in which patient was diagnosed with large B-cell lymphoma on the background of follicular lymphoma on mesenteric nodal biopsy. NL can present as a primary disease or as relapse or progression of a prior treated disease. 1, 2 Patients with NL usually present with variable symptoms ranging from progressive painful neuropathy involving one or more cranial/peripheral nerves, painful or painless cranial nerve palsies or foot drop. 2, 6 These patients are treated with systemic chemotherapy, intrathecal chemotherapy and/or radiotherapy. Despite various treatment options, there is poor prognosis for patients with NL and the disease usually follows a rapidly progressive course. 1, 3, 4 In order to diagnose NL, Doppler ultrasound can be used as initial diagnostic tool as it is non-invasive, readily available and without any radiation exposure. In the cases of NL; ultrasound demonstrates thickening of the involved nerve with increased vascularity on color Doppler images. 7 MRI and PET-CT play a key role in the diagnosis of NL with sensitivity of 87.5% and 100%, respectively. 1, 3, 8 It is very important to differentiate NL from non-cancerous conditions like inflammatory radiculopathy, Miller Fischer variant of Guillain Barre Syndrome, chemo-radiotherapy induced damage to the peripheral nervous system (PNS), paraneoplastic involvement of the PNS and neurofibromatosis. History is, therefore, very important in such cases to make the definitive diagnosis. Although, histopathology remains the gold standard in the diagnosis of NL but most patients are usually diagnosed on the basis of clinical history and imaging alone. It is also worthy to mention here that biopsy is usually performed only in Neurolymphomatosis of the sciatic and tibial nerves Also note hyper-metabolic activity in the calcaneum of 6.6 SUV which did not had any CT correlate; this could be due to focal marrow involvement. cases in which the diagnosis cannot be made on the basis of clinical history and imaging because of increased risk of permanent nerve damage. 9, 10 To conclude, NL should be in the differential diagnosis of any neuropathy, especially one that is painful and rapidly evolving in appropriate clinical setting. Radiological investigation plays a vital role, especially in cases where biopsy is difficult to perform or to avoid painful procedure.
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